Article
Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience
16 May 2014
Abstract excerpt
AIM: There is now compelling evidence that cells committed to a cardiac lineage are most effective for improving the function of infarcted hearts. This has been confirmed by our pre-clinical studies entailing transplantation of human embryonic stem cell (hESC)-derived cardiac progenitors in rat and non-human primate models of myocardial infarction. These data have paved the way for a translational programme aimed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
